Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-007516

CHIEF COMMERCIAL OFFICER bought 62,484 shares at $0.42 ($26,243)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Evanson Jeff CHIEF COMMERCIAL OFFICER 2024-03-07 Purchase +62,484 $0.42 $26,243 808,459 D
Open-market purchases · 62,484 sh · avg $0.42 · $26,243
Loading xslF345X05/form4-03112024_080303.xml…